Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized - Takeaways - MDSpire

Antiseptic Cleansing to Reduce Vertical Transmission of Pathogens to Neonates: The NeoVT-AMR Randomized

  • By

  • Emily Beales

  • Michelle N. Clements

  • Nicholas A. Feasey

  • David Lissauer

  • Maranatha Banda

  • Bertha Maseko

  • Julia A. Bielicki

  • Samantha Lissauer

  • Aisleen Bennett

  • Kondwani Kawaza

  • Luis A. Gadama

  • A. Sarah Walker

  • Mike Sharland

  • Louise F. Hill

  • June 11, 2026

  • 0 min

Share

  • 1

    Infection is a leading cause of neonatal mortality, with serious bacterial infections resulting in approximately 680,000 deaths annually in low-income countries.

  • 2

    Antiseptics like chlorhexidine and octenidine are potential preventive measures against early-onset sepsis in neonates, but evidence for their efficacy is mixed.

  • 3

    The NeoVT-AMR trial evaluated various antiseptic regimens in laboring women and neonates to reduce bacterial load and prevent neonatal sepsis.

  • 4

    The trial utilized a factorial design with multiple intervention arms, assessing the effectiveness of different antiseptic concentrations and application strategies.

  • 5

    Findings from the trial aim to inform future pragmatic studies on antiseptic use to mitigate neonatal infections and improve maternal outcomes.

Original Source(s)

Related Content